Francis Holinaty discusses his participation in WRAIR's Phase I clinical trial to test WRAIR's spike ferritin nanoparticle (SpFN) vaccine at the WRAIR Clinical Trials Center. Built on a ferritin platform, the vaccine offers a flexible approach to targeting multiple variants of the virus that causes COVID-19 and potentially other coronaviruses as well.
| Date Taken: | 04.06.2021 |
| Date Posted: | 04.06.2021 17:33 |
| Category: | Interviews |
| Video ID: | 789714 |
| VIRIN: | 210406-A-LY492-001 |
| Filename: | DOD_108267513 |
| Length: | 00:05:30 |
| Location: | MARYLAND, US |
| Downloads: | 5 |
| High-Res. Downloads: | 5 |
This work, WRAIR starts phase I clinical trials for new COVID-19 vaccine participant interview, by Arlen Caplan and Mike Walters, identified by DVIDS, must comply with the restrictions shown on https://www.dvidshub.net/about/copyright.
